Search alternatives:
designed scaffold » derived scaffold (Expand Search)
scaffold decrease » fold decrease (Expand Search)
largest decrease » larger decrease (Expand Search)
marked decrease » marked increase (Expand Search)
Showing 1 - 20 results of 2,488 for search '(( designed scaffold decrease ) OR ( a ((largest decrease) OR (marked decrease)) ))', query time: 0.48s Refine Results
  1. 1

    Development of Potent and Selective Dual PPARδ/sEH Modulators from an AI-Designed Scaffold by Xiu Ge (13802019)

    Published 2025
    “…Dual soluble epoxide hydrolase (sEH) inhibition and peroxisome proliferator-activated receptor δ (PPARδ) activation hold promise as designed polypharmacology in metabolic dysfunction and associated liver diseases by improving whole-body energy balance, decreasing hepatic inflammation and lipotoxicity, and providing cardiovascular protection. …”
  2. 2
  3. 3
  4. 4

    Osseointegration of an innovative functionally gradient biomimetic scaffold based on Voronoi-Tessellation for the design of orthopaedic implants by Yuzhu Wang (845659)

    Published 2025
    “…<p>The geometry and pore size of porous structures have a significant impact on osseointegration in orthopaedic implant design. This study introduced a new approach to designing biomimetic scaffolds using the Voronoi-Tessellation algorithm and additive manufacturing techniques. …”
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

    Published 2025
    “…<p>(a) Left: noise-evoked activity rates at different noise intensities for chronically tracked PPys cells in baseline and repeated stress conditions (<i>N</i> = 5 mice, <i>n</i> = 285 neurons, mean ± SE). …”
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    The heart rate was similar among the groups. by Hongyu Li (1332669)

    Published 2025
    “…Following the overexpression of miRNA 221 in myocardium, there was a marked alleviation of myocardial injury and cardiomyocyte apoptosis and necrosis, significant enhancement of left ventricular systolic function, and marked decrease in the levels of PLB, p-PLB (Ser16), p-PLB (Thr17), caspase 3 and Cyt C, as well as a significant decrease in total calcium levels in myocardium.…”
  20. 20

    S1 File - by Hongyu Li (1332669)

    Published 2025
    “…Following the overexpression of miRNA 221 in myocardium, there was a marked alleviation of myocardial injury and cardiomyocyte apoptosis and necrosis, significant enhancement of left ventricular systolic function, and marked decrease in the levels of PLB, p-PLB (Ser16), p-PLB (Thr17), caspase 3 and Cyt C, as well as a significant decrease in total calcium levels in myocardium.…”